These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8377421)

  • 1. [Complications of immunosuppression].
    Thiel G; Bock A; Landmann J; Mihatsch M
    Klin Monbl Augenheilkd; 1993 May; 202(5):479-84. PubMed ID: 8377421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive treatment: surveillance, toxicity, prospects].
    Giral M; Dantal J; Soulillou JP
    Rev Prat; 1994 Feb; 44(4):442-8. PubMed ID: 8184259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drugs and their effects.
    Superdock KR; Helderman JH
    Semin Respir Infect; 1993 Sep; 8(3):152-9. PubMed ID: 8016474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New immunosuppressive therapies in kidney transplantation].
    Pomer S
    Urologe A; 1994 Sep; 33(5):370-6. PubMed ID: 7974924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems with long-term immunosuppression following organ transplantation].
    Thiel G; Landmann J; Mihatsch M
    Ther Umsch; 1990 Feb; 47(2):138-46. PubMed ID: 2180103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Twenty-five years of cyclosporin use in transplantation medicine].
    Hesselink DA; van Hagen PM; Balk AH; van Hal PT; Weimar W; van Gelder T
    Ned Tijdschr Geneeskd; 2003 May; 147(20):959-64. PubMed ID: 12784529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunosuppressive strategies and the risk of infection.
    Mueller NJ
    Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunosuppressive drugs for prevention and treatment of rejection in renal transplant.
    Segoloni GP; Quaglia M
    J Nephrol; 2006; 19(5):578-86. PubMed ID: 17136684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with cyclosporine in endogenous uveitis posterior.
    Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM
    Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppression in corneal transplantation].
    Scheer S; Touzeau O; Borderie V; Laroche L
    J Fr Ophtalmol; 2003 Jun; 26(6):637-47. PubMed ID: 12910207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coping with rejection: immunosuppressants and organ transplantation.
    Woodcock J
    Drug Discov Today; 2005 Jan; 10(1):11-3. PubMed ID: 15676293
    [No Abstract]   [Full Text] [Related]  

  • 14. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-toxicity immunosuppressive therapy in renal transplant].
    Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of immunosuppression--what patients really think.
    Newstead CG
    Nephron Clin Pract; 2004; 97(2):c31-2. PubMed ID: 15218326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.